D-0094-2024 Class III Ongoing
FDA drug recall D-0094-2024 was initiated by Zyla Life Sciences US Inc. on Oct 20, 2023 and is designated Class III. Reason for recall: Sub-potent Drug: Lower potency than labeled. The recall status is ongoing. Affected quantity: 3,792 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 15, 2023
- Initiation Date
- Oct 20, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,792 bottles
Product description
Oxaydo (oxycodone HCl, USP) tablets, 7.5 mg, 100 Tablets per bottle, Rx only, Distributed by: Zyla Life Sciences US Inc., Wayne, PA 19087. NDC: 69344-213-11
Reason for recall
Sub-potent Drug: Lower potency than labeled.
Distribution pattern
Nationwide
Code information
Lot 22W02, Exp 01/31/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0094-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026